Risk factors for nursing home placement in Alzheimer's disease: a longitudinal study of cognition, ADL, service utilization, and cholinesterase inhibitor treatment.

scientific article

Risk factors for nursing home placement in Alzheimer's disease: a longitudinal study of cognition, ADL, service utilization, and cholinesterase inhibitor treatment. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/GERONT/GNQ050
P698PubMed publication ID20562471

P50authorLennart MinthonQ66724775
Elisabet LondosQ66724780
Carina WattmoQ92523170
Åsa K WallinQ114405447
P2860cites workDeterminants of costs of care for patients with Alzheimer's diseaseQ22252908
“Mini-mental state”Q25938989
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's DiseaseQ27860795
Factors associated with long-term institutionalization of older people with dementia: data from the Canadian Study of Health and AgingQ30664600
Predicting nursing home admission in the U.S: a meta-analysisQ33288191
Predicting time to nursing home placement based on activities of daily living scores--a modelling analysis using data on Alzheimer's disease patients receiving rivastigmine or donepezilQ33459417
Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial.Q33979412
Patient and caregiver characteristics and nursing home placement in patients with dementiaQ34609100
Cholinesterase inhibitor treatment alters the natural history of Alzheimer's diseaseQ35465836
Activities of daily living in patients with dementia: clinical relevance, methods of assessment and effects of treatmentQ35936874
Patients with Lewy body dementia use more resources than those with Alzheimer's diseaseQ36694930
Prediction of institutionalisation in dementia. A systematic reviewQ37212656
Predictors of nursing home admission for persons with dementia.Q37377302
The prevalence of dementia in a statewide sample of new nursing home admissions aged 65 and older: diagnosis by expert panel. Epidemiology of Dementia in Nursing Homes Research GroupQ39555113
Predictors of institutionalization for people with dementia living at home with a carerQ40835242
Predictors of time to institutionalization of patients with Alzheimer's disease: the CERAD experience, part XVII.Q40896300
Long-term tacrine (Cognex) treatment: effects on nursing home placement and mortality, Tacrine Study GroupQ40935673
A longitudinal study of predictors of nursing home placement for patients with dementia: the contribution of family characteristicsQ41716596
Donepezil is associated with delayed nursing home placement in patients with Alzheimer's diseaseQ42602615
Five-year outcome of cholinergic treatment of Alzheimer's disease: early response predicts prolonged time until nursing home placement, but does not alter life expectancyQ42629825
Caregiving and institutionalization of cognitively impaired older people: utilizing dynamic predictors of changeQ47992269
Functional decline in Alzheimer's disease: a longitudinal study.Q50609494
Access to health care in the Scandinavian countries: ethical aspects.Q51081214
Donepezil in Alzheimer's disease: what to expect after 3 years of treatment in a routine clinical setting.Q51906755
Alteration of a clinically meaningful outcome in the natural history of Alzheimer's disease by cholinesterase inhibition.Q51933837
Outcome of Alzheimer's disease: potential impact of cholinesterase inhibitors.Q53379069
The Effect of Adult Day Care Services on Time to Nursing Home Placement in Older Adults With Alzheimer's DiseaseQ56535882
P433issue1
P921main subjectAlzheimer's diseaseQ11081
P304page(s)17-27
P577publication date2010-06-20
P1433published inGerontologistQ15757423
P1476titleRisk factors for nursing home placement in Alzheimer's disease: a longitudinal study of cognition, ADL, service utilization, and cholinesterase inhibitor treatment.
P478volume51

Reverse relations

cites work (P2860)
Q36723409A longitudinal study of risk factors for community-based home help services in Alzheimer's disease: the influence of cholinesterase inhibitor therapy
Q26859831A practical algorithm for managing Alzheimer's disease: what, when, and why?
Q37874387A review of the methods used to estimate the cost of Alzheimer's disease in the United States
Q37342379A three-year follow-up on the efficacy of psychosocial interventions for patients with mild dementia and their caregivers: the multicentre, rater-blinded, randomised Danish Alzheimer Intervention Study (DAISY).
Q47558398Adverse Events in Home Care: Identifying and Responding with interRAI Scales and Clinical Assessment Protocols
Q36818214Biomarkers of basic activities of daily living in Alzheimer's disease.
Q92523174Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer's disease
Q41026604Changes of Health Status and Institutionalization Among Older Adults in China
Q36118948Cholinesterase inhibitors do not alter the length of stay in nursing homes among patients with Alzheimer's disease: a prospective, observational study of factors affecting survival time from admission to death
Q28067006Clinical Recommendations for the Use of Donepezil 23 mg in Moderate-to-Severe Alzheimer's Disease in the Asia-Pacific Region
Q50981551Clinical and cost implications of amyloid beta detection with amyloid beta positron emission tomography imaging in early Alzheimer's disease - the case of florbetapir.
Q37708297Cost-effectiveness of cerebrospinal biomarkers for the diagnosis of Alzheimer's disease
Q40205836Deciding to institutionalize: caregiving crisis, intergenerational communication, and uncertainty management for elders and their children in Shanghai
Q47549454Dementia, Disclosing the Diagnosis
Q38635319Discharge Home From Hospital: How DIRE Can It Be?
Q33801636Early-versus Late-Onset Alzheimer Disease: Long-Term Functional Outcomes, Nursing Home Placement, and Risk Factors for Rate of Progression
Q53323073Economic evaluation of the impact of memantine on time to nursing home admission in the treatment of Alzheimer disease.
Q36165980Efficacy of 13.3 mg/24 h versus 4.6 mg/24 h rivastigmine patch on activities of daily living in severe Alzheimer's disease
Q44542466Efficacy of higher dose 13.3 mg/24 h rivastigmine patch on instrumental activities of daily living in patients with mild-to-moderate Alzheimer's disease
Q51491144Efficacy of rivastigmine tartrate, transdermal system, in Alzheimer's disease.
Q38934118Factors related to continuous and discontinuous attendance at memory clinics
Q34466802Functional response to cholinesterase inhibitor therapy in a naturalistic Alzheimer's disease cohort
Q36058935Gender Differences in Institutional Long-Term Care Transitions
Q41120871Group and individual cognitive therapies in Alzheimer's disease: the ETNA3 randomized trial
Q30863627Health Care Service Utilization of Dementia Patients before and after Institutionalization: A Claims Data Analysis
Q44012664Health economic analysis on a psychosocial intervention for family caregivers of persons with dementia.
Q55075325Healthcare costs for the elderly in Japan: Analysis of medical care and long-term care claim records.
Q33685782Increased health service utilization costs in the year prior to institutionalization: findings from the canadian study of health and aging.
Q89075763Is Episodic Future Thinking Important for Instrumental Activities of Daily Living? A Study in Neurological Patients and Healthy Older Adults
Q41031505Living Alone with Alzheimer's Disease and the Risk of Adverse Outcomes: Results from the Plan de Soin et d'Aide dans la maladie d'Alzheimer Study
Q36515587Management of patients with Alzheimer's disease: pharmacological treatment and quality of life
Q47630333Men Lacking a Caregiver Have Greater Risk of Long-Term Nursing Home Placement After Stroke
Q46001072People with dementia in long-term care facilities: an exploratory study of their activities and participation.
Q51411416Predictors of Institutionalization in Patients with Alzheimer's Disease in South Korea.
Q38798301Predictors of long-term care placement in persons with dementia: a systematic review and meta-analysis
Q35579243Predictors of long-term cognitive outcome in Alzheimer's disease
Q37690649Progression of mild Alzheimer's disease: knowledge and prediction models required for future treatment strategies
Q48439989Randomized, double-blind, parallel-group, 48-week study for efficacy and safety of a higher-dose rivastigmine patch (15 vs. 10 cm²) in Alzheimer's disease
Q36264977Real-world evaluation of compliance and preference in Alzheimer's disease treatment
Q35158572Responder analysis of a randomized comparison of the 13.3 mg/24 h and 9.5 mg/24 h rivastigmine patch
Q34233759Response to cholinesterase inhibitors affects lifespan in Alzheimer's disease
Q47862426Short-Term Response is not Predictive of Long-Term Response to Acetylcholinesterase Inhibitors in Old Age Subjects with Alzheimer's Disease: A "Real World" Study
Q53397893Short-Term Response to Cholinesterase Inhibitors in Alzheimer's Disease Delays Time to Nursing Home Placement.
Q34548336Solitary living in Alzheimer's disease over 3 years: association between cognitive and functional impairment and community-based services
Q38101072Systematic review of non-pharmacologic interventions to delay functional decline in community-dwelling patients with dementia
Q46305050The Effect of Adult Day Services on Delay to Institutional Placement
Q57177786The cholinergic system in the pathophysiology and treatment of Alzheimer's disease
Q38197992The effectiveness of adult day services for older adults: a review of the literature from 2000 to 2011.
Q59336971The impact of attending day care designed for home-dwelling people with dementia on nursing home admission: a 24-month controlled study
Q55439713Time-varying effects of socio-demographic and economic factors on the use of institutional long-term care before dementia-related death: A Finnish register-based study.
Q35967441Transitions in care for older adults with and without dementia
Q37632894Use of health and social care services in a cohort of Italian dementia patients
Q37576656Vascular biomarkers to predict response to exercise in Alzheimer's disease: the study protocol.
Q96427847[Factors influencing the decision to age in place despite the need for nursing interventions: a systematic review]

Search more.